개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술대회자료
- 저자정보
- 발행연도
- 2021.6
- 수록면
- 40 - 41 (2page)
이용수
초록· 키워드
오류제보하기
Neoadjuvant chemoradiotherapy followed by total mesorectal excision has represented standard treatment for locally advanced rectal cancer and adjuvant chemotherapy because it was proved to reduce local recurrence significantly. The majority of patients with locally advanced rectal cancer, however, still suffer distant metastasis. Indeed, advances in local control have not translated into overall survival improvement. Current treatment modalities are also challenged in terms of tumor response. Tumor response to radiation therapy would progress further with longer interval to definite treatment or evaluation. However, based on its initial advanced stage, just wait without any treatment impose risk of disease progression. Addition of additional chemotherapy would be proposed to facilitate prolong waiting period.
One of the issues with current rectal cancer treatment scheme has been poor compliance with adjuvant chemotherapy. Chronicle study reported that only 48% of patients with stage III rectal cancer completed 6 cycles adjuvant XELOX. EORTC 22921 showed that less than 43% of patients with stage II/III rectal cancer completed adjuvant 5FU-based chemotherapy. To solve poor compliance, administration the whol^_@span style=color:#999999 ^_# ... ^_@/span^_#^_@a href=javascript:; onclick=onClickReadNode('NODE10593427');fn_statistics('Z354','null','null'); style='color:#999999;font-size:14px;text-decoration:underline;' ^_#전체 초록 보기^_@/a^_#
One of the issues with current rectal cancer treatment scheme has been poor compliance with adjuvant chemotherapy. Chronicle study reported that only 48% of patients with stage III rectal cancer completed 6 cycles adjuvant XELOX. EORTC 22921 showed that less than 43% of patients with stage II/III rectal cancer completed adjuvant 5FU-based chemotherapy. To solve poor compliance, administration the whol^_@span style=color:#999999 ^_# ... ^_@/span^_#^_@a href=javascript:; onclick=onClickReadNode('NODE10593427');fn_statistics('Z354','null','null'); style='color:#999999;font-size:14px;text-decoration:underline;' ^_#전체 초록 보기^_@/a^_#
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Annals of Coloproctology
2019 .01
-
Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
전남의대학술지
2023 .01
-
Impact of Adjuvant Therapy Type on Survival in Stage II/III Rectal Cancer Without Preoperative Chemoradiation: A Korean Multicenter Retrospective Study
Annals of Coloproctology
2018 .01
-
Oncologic effects of adjuvant chemotherapy in patients with ypT0-2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis
Annals of Surgical Treatment and Research
2020 .08
-
Modifications to Treatment Plan of Rectal Cancer in Response to COVID-19 at the Philippine General Hospital
Annals of Coloproctology
2021 .08
-
Recent Update of Total Neoadjuvant Therapy for Rectal Cancer
대한외과학회 학술대회 초록집
2022 .05
-
Treatment Outcomes of Neoadjuvant Chemoradiation Therapy for Rectal Cancer Patients: A Nationwide Population-based Cohort Study in Korea
대한외과학회 학술대회 초록집
2020 .11
-
Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer : long-term oncologic outcomes
Annals of Surgical Treatment and Research
2018 .06
-
Local Recurrence after Neoadjuvant Chemoradiotherapy And Rectal Excision in Rectal Cancer Patients When The Distal Resection Margin Is Compromised
대한외과학회 학술대회 초록집
2020 .11
-
Advances in surgery for locally advanced rectal cancer
Annals of Coloproctology
2022 .08
-
Impact of Time Interval Between Chemoradiation and Surgery on Pathological Complete Response and Survival in Rectal Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
Radiation oncology journal : ROJ
2016 .01
-
Early Systemic Failure After Preoperative Chemoradiotherapy for the Treatment of Patients With Rectal Cancer
Annals of Coloproctology
2019 .01
-
Clinical characteristics of rectal cancer patients with neoadjuvant chemoradiotherapy: a nationwide population-based cohort study in South Korea
Annals of Surgical Treatment and Research
2021 .05
-
Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer: a preliminary case series study
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2021 .12
-
Characteristics of patients presented with metastases during or after completion of chemo-radiation therapy (CRT) for locally advanced rectal cancer: a case series
Annals of Coloproctology
2021 .01
-
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Cancer Research and Treatment
2022 .01
-
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
Journal of Breast Cancer
2019 .01
-
Appropriate Timing of Surgery after Neoadjuvant Chemo-Radiation Therapy for Locally Advanced Rectal Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Treatment of recurrence after local excision of rectal cancer
대한외과학회 학술대회 초록집
2019 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2021-514-001918973